IRIS
CALCATERRA, ILENIA LORENZA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.676
EU - Europa 1.211
NA - Nord America 1.117
SA - Sud America 220
AF - Africa 37
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 4.264
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.072
SG - Singapore 891
RU - Federazione Russa 632
CN - Cina 398
IT - Italia 280
BR - Brasile 162
HK - Hong Kong 143
VN - Vietnam 104
DE - Germania 76
GB - Regno Unito 40
IN - India 40
FR - Francia 36
FI - Finlandia 33
KR - Corea 29
NL - Olanda 29
AR - Argentina 22
CA - Canada 20
MX - Messico 18
UA - Ucraina 17
ID - Indonesia 15
AT - Austria 13
BD - Bangladesh 13
ZA - Sudafrica 12
CI - Costa d'Avorio 11
EC - Ecuador 11
PL - Polonia 9
CO - Colombia 7
IE - Irlanda 7
JP - Giappone 7
SE - Svezia 7
PK - Pakistan 6
VE - Venezuela 6
GR - Grecia 5
IQ - Iraq 5
PY - Paraguay 5
TR - Turchia 5
CH - Svizzera 4
ES - Italia 4
LT - Lituania 4
DZ - Algeria 3
KE - Kenya 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AM - Armenia 2
AZ - Azerbaigian 2
CL - Cile 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
EE - Estonia 2
HR - Croazia 2
NI - Nicaragua 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
AU - Australia 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BJ - Benin 1
BO - Bolivia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GE - Georgia 1
GF - Guiana Francese 1
GP - Guadalupe 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
JO - Giordania 1
MA - Marocco 1
MK - Macedonia 1
MN - Mongolia 1
NA - Namibia 1
NP - Nepal 1
SA - Arabia Saudita 1
SN - Senegal 1
SO - Somalia 1
UY - Uruguay 1
YE - Yemen 1
Totale 4.264
Salva come PNG Salva come JPEG
Città #
Singapore 441
Hefei 171
Ashburn 154
Hong Kong 143
Moscow 140
Chandler 114
Beijing 80
Santa Clara 75
Naples 67
Ho Chi Minh City 46
Boardman 43
Los Angeles 40
Millbury 37
Dallas 34
Lawrence 29
Seoul 29
Buffalo 27
Hanoi 26
Des Moines 23
San Jose 20
Munich 19
Amsterdam 17
New York 17
Redondo Beach 17
Helsinki 16
Seattle 15
Napoli 14
Boston 12
Frankfurt am Main 12
Nuremberg 12
Turku 12
Milan 11
São Paulo 11
Castel Volturno 9
Orem 9
The Dalles 9
Washington 9
Düsseldorf 8
Lauterbourg 8
Portsmouth 8
Pune 8
Rio de Janeiro 8
Sorrento 8
Wilmington 8
Houston 7
Stockholm 7
Warsaw 7
Belo Horizonte 6
Brooklyn 6
Changsha 6
Denver 6
Shanghai 6
Tokyo 6
Chennai 5
Falkenstein 5
Formia 5
London 5
Marsala 5
Mexico City 5
Montreal 5
Palermo 5
San Francisco 5
Woodbridge 5
Xi'an 5
Asunción 4
Belvedere Marittimo 4
Brasília 4
Curitiba 4
Dublin 4
Ercolano 4
Lappeenranta 4
Manchester 4
Ottawa 4
Toronto 4
Zurich 4
Afragola 3
Bexley 3
Biên Hòa 3
Chicago 3
Cologno Al Serio 3
Da Nang 3
Dhaka 3
Fairfield 3
Guayaquil 3
Ha Long 3
Haiphong 3
Hải Dương 3
Istanbul 3
Johannesburg 3
Medellín 3
Monte San Savino 3
Nairobi 3
New Delhi 3
Pittsburgh 3
Poplar 3
Quito 3
Rome 3
Roubaix 3
Tampa 3
Tashkent 3
Totale 2.247
Salva come PNG Salva come JPEG
Nome #
Effects of Armolipid Plus on small dense LDL particles in a sample of patients affected by familial combined hyperlipidemia 122
A wide next-generation-sequencing panel improves the molecular diagnosis of dyslipidemias 122
Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia: Systematic Review and Meta-Analysis of Randomized Controlled Trials 117
Lipoprotein(A) where do we stand? from the physiopathology to innovative terapy 112
Genetic spectrum of familial hypercholesterolemia and correlations with clinical expression: Implications for diagnosis improvement 109
Association between causative mutations and response to PCSK9 inhibitor therapy in subjects with familial hypercholesterolemia: A single center real-world study 107
Efficacy and safety of direct oral anticoagulants in splanchnic vein thrombosis: a pooled analysis of literature studies 103
Authors’ response to letter by Sbrana et al. “Evolocumab improve intima media thickness regression in He-FH subjects on lipoprotein apheresis” 102
An untargeted lipidomic analysis reveals depletion of several phospholipid classes in patients with familial hypercholesterolemia on treatment with evolocumab 101
Sex-related differences in response to lomitapide in HoFH: A subanalysis of the Pan-European Lomitapide retrospective observational study 99
Clinical assessment of endothelial function in heart failure with preserved ejection fraction: A meta-analysis with meta-regressions 99
Association of apolipoprotein levels with peripheral arterial disease: a meta-analysis of literature studies 98
Carotid Atherosclerosis, Ultrasound and Lipoproteins 96
Clinical assessment of endothelial function in convalescent covid-19 patients undergoing multidisciplinary pulmonary rehabilitation 96
A Real-World Experience of Clinical, Biochemical and Genetic Assessment of Patients with Homozygous Familial Hypercholesterolemia 95
Cardiovascular disease and antiphospholipid syndrome: how to predict and how to treat? 94
Assessment of Platelet Aggregation and Thrombin Generation in Patients with Familial Chylomicronemia Syndrome Treated with Volanesorsen: A Cross-Sectional Study 93
SMALL DENSE LDL IN RELATION TO CHANGES IN OXIDATION MARKERS AND VASCULAR REACTIVITYIN PATIENTS WITH HYPERCHOLESTEROLEMIA TREATED WITH EVOLOCUMAB: A PROSPECTIVE COHORT STUDY 93
Endothelial function improvement in patients with familial hypercholesterolemia receiving PCSK-9 inhibitors on top of maximally tolerated lipid lowering therapy 93
Association of systemic lupus erythematosus with peripheral arterial disease: a meta-analysis of literature studies 93
Pathophysiological Role of Synovitis in Hemophilic Arthropathy Development: A Two-Hit Hypothesis 92
EVOLOCUMAB IS EFFECTIVE AND SAFE TO TREAT HYPERCHOLESTEROLEMIA IN A PATIENT WITH STATIN-INDUCED NECROTIZING MYOPATHY 91
Changes in carotid stiffness in patients with familial hypercholesterolemia treated with Evolocumab®: A prospective cohort study 91
Persistent endothelial dysfunction in post-acute covid-19 syndrome: A case-control study 89
Impact of 12-SNP and 6-SNP Polygenic Scores on Predisposition to High LDL-Cholesterol Levels in Patients with Familial Hypercholesterolemia 88
Changes in markers of subclinical atherosclerosis in patients with familial hypercholesterolemia treated with evolocumab: a prospective cohort study 87
Treatment with pcsk9 inhibitors in patients with familial hypercholesterolemia lowers plasma levels of platelet-activating factor and its precursors: A combined metabolomic and lipidomic approach 87
Diagnostic accuracy of D-Dimer testing for recurrent venous thromboembolism: A systematic review with meta-analysis.: VTE recurrence and D-dimer 85
Vascular effects of the polyphenolic nutraceutical supplement taurisolo®: Focus on the protection of the endothelial function 85
Evinacumab for Homozygous Familial Hypercholesterolemia: The Italian Cohort of the ELIPSE HoFH Study 81
Risk assessment and antithrombotic strategies in antiphospholipid antibody carriers 81
Post-Bariatric Hypoglycemia Is Associated with Endothelial Dysfunction and Increased Oxidative Stress 81
COVID-19 and Venous Thromboembolism: A Meta-analysis of Literature Studies 77
Direct-acting antivirals improve endothelial function in patients with chronic hepatitis: a prospective cohort study 73
Homozygous Familial Hypercholesterolemia in Campania 72
Endothelial Dysfunction in COVID-19: A Unifying Mechanism and a Potential Therapeutic Target 71
Alirocumab in high cardiovascular risk patients with Heterozygous Familial Hypercholesterolemia: Efficacy and safety in lipid lowering levels 70
New insights into the management of homozygous familial hypercholesterolemia patients treated with lomitapide: a single-center experience 68
Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Insights from Pivotal and Extension Studies 67
Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Final Results from Extension Studies 66
SHORT-TERM VARIABILITY OF 24-H SYSTOLIC BLOOD PRESSURE IS ASSOCIATED WITH MICROALBUMINURIA IN PATIENTS WITH PRIMARY HYPERTENSION 65
Evidence of subclinical atherosclerosis in eosinophilic granulomatosis with polyangiitis 62
Hemostatic Changes in Patients with COVID-19: A Meta-Analysis with Meta-Regressions 59
Prediction of the chance of successful immune tolerance induction in persons with severe hemophilia A and inhibitors: a clinical prediction model 57
Volanesorsen to treat severe hypertriglyceridaemia: A pooled analysis of randomized controlled trials 57
Intensive FVIII replacement in haemophilia patients with hypertrophic synovium: a randomized study 54
Effects of Mediterranean Diet on Endothelial Reactivity in Individuals with High Cardiometabolic Risk: A Randomized Controlled Parallel-Group Preliminary Trial 52
Metabolic syndrome in hypertensive patients: An unholy alliance 51
Relationship Between Short-Term Blood Pressure Variability and Subclinical Renal Damage in Essential Hypertensive Patients 50
The evolving landscape of gene therapy for congenital severe hemophilia: a 2024 state of the art 47
Joint health status in people with moderate hemophilia A: a cross-sectional multicenter study 46
Average real variability of 24-h systolic blood pressure is associated with microalbuminuria in patients with primary hypertension 44
Plasma aldosterone and its relationship with left ventricular mass in hypertensive patients with early-stage chronic kidney disease 32
Acquired Hemophilia A in a Case of Relapsed Immune Thrombotic Thrombocytopenic Purpura 26
Totale 4.348
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.515
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.515
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202129 0 0 0 0 0 0 2 1 3 1 16 6
2021/2022231 0 7 7 0 11 11 1 7 3 22 92 70
2022/2023267 30 19 11 8 39 33 3 40 38 17 18 11
2023/2024306 22 35 19 19 18 65 3 22 2 6 28 67
2024/20251.570 58 54 37 69 23 122 149 103 78 193 551 133
2025/20261.880 318 295 349 291 503 96 28 0 0 0 0 0
Totale 4.348